Host metalloproteinases in lyme arthritis

Arthritis and Rheumatism

Volumn 44, Issue 6, 2001, Pages 1401-1410

  Hu, Linden T ^a   Eskildsen, Manuel A ^a   Masgala, Catherine ^b   Steere, Allen C ^b   Arner, Elizabeth C ^a   Pratta, Michael A ^a   Grodzinsky, Alan J ^c   Loening, Andrew ^c   Perides, George ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b DUPONT COMPANY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE; COLLAGEN; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; METALLOPROTEINASE; PLASMINOGEN; STROMELYSIN;

ARTICLE; BONE EROSION; BORRELIA BURGDORFERI; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; LYME DISEASE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SYNOVIAL FLUID LEVEL; ZYMOGRAPHY;

ANIMALS; ARTHRITIS, INFECTIOUS; BLOTTING, WESTERN; BORRELIA BURGDORFERI GROUP; CARTILAGE; CATTLE; CULTURE TECHNIQUES; DNA, BACTERIAL; ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HUMANS; KNEE JOINT; LYME DISEASE; MATRIX METALLOPROTEINASES; POLYMERASE CHAIN REACTION; SYNOVIAL FLUID;

EID: 0034966506     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200106)44:6<1401::AID-ART234>3.0.CO;2-S     Document Type: Article

References (60)

1. The clinical evolution of Lyme arthritis
2. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: Comparison with rheumatoid synovium and tonsillar lymphoid tissue
3. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
4. Lyme disease
5. Borrelia burgdorferi possesses a collagenolytic activity
6. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi
7. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures
8. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi
9. Lyme disease spirochetes induce human and murine interleukin 1 production
10. Isolation of interleukin 1 from joint fluids of patients with Lyme disease
11. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi
12. Cytokines in synovial fluid: The presence of tumor necrosis factor and interferon
13. Release of interleukin-1 from human synovial tissue in vitro
14. Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis
15. Regulation of matrix metalloproteinase gene expression
16. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis
17. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis
18. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
19. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis
20. The effects of interferon-β treatment on synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis
21. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells: Regulation by tumor necrosis factor-alpha and doxycycline
22. A study of metalloproteinases in fifty joint fluid specimens
23. Development of a cleavage site specific monoclonal antibody for detecting metalloproteinases-derived aggrecan fragments: Detection of fragments in human synovial fluids
24. The structure of aggrecan fragments in human synovial fluid: Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis
25. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family
26. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites: Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan
27. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
28. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease
29. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma
30. A fluorescent enzyme-linked immunosorbent assay (FELISA)for stromelysin using a polyclonal antisera to human stromelysin with broad species cross-reactivity
31. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors
32. Isolation and cultivation of Lyme disease spirochetes
33. Binding of human plasminogen to Borrelia burgdorferi
34. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
35. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor
36. Glial hyaluronate-binding protein: A product of metalloproteinase digestion of versican?
37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
38. Generation and characterization of aggrecanase: A soluble, cartilage-derived aggrecan-degrading activity
39. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis
40. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluid of patients with arthritis: Correlation with clinical and experimental variables of inflammation
41. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium
42. Aggrecan degradation in human cartilage: Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
43. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis
44. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium
45. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: Application to catabolism in situ and in vitro
46. Membrane-type matrix metalloproteinase and cell surface-associated activation cascades for matrix metalloproteinases
47. Animal models of Lyme disease: Pathogenesis and immunoprophylaxis
48. Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture
49. Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants: The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP
50. Lyme arthritis: Radiologic findings
51. Interstitial collagenases
52. Matrix metalloproteinases
53. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor
54. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers
55. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
56. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release
57. Membrane protein secretases
58. Monocyte-macrophage antigen expression on chondrocytes
59. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis
60. Involvement of MMP-1 and MMP-3 in collagen degradation induced by IL-1 in rabbit cartilage explant culture